Invert sugar - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for invert sugar and what is the scope of patent protection?
Invert sugar
is the generic ingredient in one branded drug marketed by Baxter Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for invert sugar
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 2 |
Patent Applications: | 5,211 |
Formulation / Manufacturing: | see details |
DailyMed Link: | invert sugar at DailyMed |
Recent Clinical Trials for invert sugar
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 3 |
University of Calgary | N/A |
US Patents and Regulatory Information for invert sugar
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | TRAVERT 10% IN PLASTIC CONTAINER | invert sugar | INJECTABLE;INJECTION | 016717-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |